Jalalabadi Faryan, Grome Luke, Shahrestani Navid, Izaddoost Shayan A, Reece Edward M
Division of Plastic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Early Venture Banking, Silicon Valley Bank, Los Angeles, California.
Semin Plast Surg. 2018 Nov;32(4):179-181. doi: 10.1055/s-0038-1672168. Epub 2018 Oct 22.
Innovation is vital for progress in any industry. Evolving technology, paired with human ingenuity, brings ideas for prototypes and business models. Many physicians conceptualize platforms to serve their patients; however, many struggle and ultimately fail to bring their product or service to market. Financing is often the limiting factor. Studies have proven venture capital (VC) funding to be a pivotal source for helping a business survive in its early stages. Plastic surgeons can benefit from learning how to seek out VC funding. In this presentation, common terminology and key players will be defined, from seed capital to angel investors. Doing recommended "homework" will help the plastic surgeon identify a financier tailored to their specific needs-ideally one with a focus in the medical space. A clear-cut approach to assembling a "pitch deck" presentation will be outlined to prepare the plastic surgeon for their first meeting. Insider pearls will be presented from the VC perspective. The plastic surgeon should be prepared to answer fundamental questions expected at different stages of the process. Nevertheless, each meeting also serves as an opportunity for the plastic surgeon to probe the VC firm and their intentions. The role of background checks, social media, and electronic profiles will be discussed. Transparency from both parties at all times can help establish a successful relationship, even if it ends in a referral to a better suited VC firm. Between January and September of 2017, $12.1 billion of seed and VC was invested into life science companies in the United States. Growth is exponential. The surgeon is at the frontier of developing ideas and cutting-edge products that help us serve our patients with enhanced care and improved outcomes. In seeking out the proper financier, your product or service can become a reality in the market, contributing to the betterment of medicine and plastic surgery.
创新对于任何行业的发展都至关重要。不断发展的技术与人类的创造力相结合,催生了原型和商业模式的创意。许多医生构思出为患者服务的平台;然而,许多人却遭遇困难,最终未能将其产品或服务推向市场。融资往往是限制因素。研究证明,风险投资(VC)资金是帮助企业在早期阶段生存的关键来源。整形外科医生可以从学习如何寻求风险投资资金中受益。在本演讲中,将定义从种子资金到天使投资者的常见术语和关键参与者。做好推荐的“功课”将有助于整形外科医生找到符合其特定需求的 financier——理想情况下是专注于医疗领域的 financier。将概述一种清晰的方法来组装“推介资料”演示文稿,为整形外科医生的首次会面做好准备。将从风险投资的角度介绍一些内部诀窍。整形外科医生应准备好回答该过程不同阶段可能会被问到的基本问题。尽管如此,每次会面也是整形外科医生探究风险投资公司及其意图的机会。将讨论背景调查、社交媒体和电子档案的作用。双方始终保持透明有助于建立成功的关系,即使最终只是被推荐给更合适的风险投资公司。在2017年1月至9月期间,美国生命科学公司获得了121亿美元的种子资金和风险投资。增长呈指数级。外科医生处于开发有助于我们以更好的护理和改善的结果为患者服务的创意和前沿产品的前沿。在寻找合适的 financier时,你的产品或服务可以在市场上成为现实,为医学和整形外科的发展做出贡献。